← Back to Clinical Trials
Recruiting NCT04659824

NCT04659824 Study of Iron Accumulation Measured in MRI in Non-pathological Aging

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04659824
Status Recruiting
Phase
Sponsor University Hospital, Lille
Condition Healthy Aging
Study Type OBSERVATIONAL
Enrollment 190 participants
Start Date 2023-01-30
Primary Completion 2029-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 95 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 190 participants in total. It began in 2023-01-30 with a primary completion date of 2029-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To study the correlation between the iron load in brain, measured in MRI, and the age of healthy subjects Secondary objectives are to study the correlations between the iron load in cortical brain regions and (i) the cognitive performances, (ii) markers of aging (MRI, EEG, OCT, biology),and (iii) demographical factors involved in iron load.

Eligibility Criteria

Inclusion Criteria: * Men or women between 18 and 95 years old * French speaker with capability to understand the instructions * Health insurance Exclusion Criteria: * Pregnancy * minor subject * no informed consent agreement * subject enrolled in pharmaceutic study or exclusion period * MRI contra-indications * Neurological or psychiatric disorders * MOCA \< 26 * Psychotropic drugs * More than 3 MRI exams * More than 1 neuropsychological assessment (same cognitive tests) in the last 12 months * Unable to follow the entire protocol according to the investigator

Contact & Investigator

Central Contact

Grégory KUCHCINSKI, MD

✉ gregory.kuchcinski@chru-lille.fr

📞 0320445962

Principal Investigator

Grégory KUCHCINSKI, MD

PRINCIPAL INVESTIGATOR

University Hospital, Lille

Frequently Asked Questions

Who can join the NCT04659824 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 95 Years, studying Healthy Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04659824 currently recruiting?

Yes, NCT04659824 is actively recruiting participants. Contact the research team at gregory.kuchcinski@chru-lille.fr for enrollment information.

Where is the NCT04659824 trial being conducted?

This trial is being conducted at Lille, France.

Who is sponsoring the NCT04659824 clinical trial?

NCT04659824 is sponsored by University Hospital, Lille. The principal investigator is Grégory KUCHCINSKI, MD at University Hospital, Lille. The trial plans to enroll 190 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology